Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Daunorubicin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Burkitt Lymphoma 9 Myelodysplastic Syndromes 7 Leukemia 7 Myeloproliferative Disorders 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Sarcoma, Myeloid 2 Neoplasm, Residual 2 Leukemia, Monocytic, Acute 2 Down Syndrome 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Philadelphia Chromosome 1 Mucositis 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Acute Myeloid Leukemia With KMT2A Rearrangement 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡